These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan. Tahaineh L; Albsoul-Younes A; Al-Ashqar E; Habeb A Int J Clin Pharm; 2011 Apr; 33(2):229-36. PubMed ID: 21744191 [TBL] [Abstract][Full Text] [Related]
4. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. Mazzolini TA; Irons BK; Schell EC; Seifert CF J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420 [TBL] [Abstract][Full Text] [Related]
5. Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits. Hinds A; Lopez D; Rascati K; Jokerst J; Srinivasa M Diabetes Educ; 2016 Apr; 42(2):228-33. PubMed ID: 26902526 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of a pharmacy care management program for veterans with dyslipidemia. Smith MC; Boldt AS; Walston CM; Zillich AJ Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745 [TBL] [Abstract][Full Text] [Related]
8. Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence. Vashitz G; Meyer J; Parmet Y; Henkin Y; Peleg R; Gilutz H Fam Pract; 2011 Oct; 28(5):524-31. PubMed ID: 21566005 [TBL] [Abstract][Full Text] [Related]
9. A community pharmacist delivered adherence support service for dyslipidaemia. Aslani P; Rose G; Chen TF; Whitehead PA; Krass I Eur J Public Health; 2011 Oct; 21(5):567-72. PubMed ID: 20817685 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Collins C; Kramer A; O'Day ME; Low MB Am J Health Syst Pharm; 2006 Sep; 63(18):1723-7. PubMed ID: 16960256 [TBL] [Abstract][Full Text] [Related]
11. Pharmacists role in cholesterol management: addressing challenges and barriers. Manigault KR; Lewis KA J Pharm Pract; 2015 Feb; 28(1):35-43. PubMed ID: 25500555 [TBL] [Abstract][Full Text] [Related]
12. Impact of a multidisciplinary intervention on antibiotic use for nursing home-acquired pneumonia. Linnebur SA; Fish DN; Ruscin JM; Radcliff TA; Oman KS; Fink R; Van Dorsten B; Liebrecht D; Fish R; McNulty M; Hutt E Am J Geriatr Pharmacother; 2011 Dec; 9(6):442-450.e1. PubMed ID: 22055208 [TBL] [Abstract][Full Text] [Related]
13. Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. Bailey TC; Noirot LA; Gage BF; Li X; Shannon WD; Waterman B; Sinha S; Bouselli DA; Reichley RM; Goldberg AC; Dunagan WC AMIA Annu Symp Proc; 2006; 2006():850. PubMed ID: 17238470 [TBL] [Abstract][Full Text] [Related]
14. Perceptions about the management of dyslipidaemia among physicians in Jamaica and Trinidad. Monsanto HA; Prann M; Quijada JG West Indian Med J; 2007 Sep; 56(4):334-40. PubMed ID: 18198738 [TBL] [Abstract][Full Text] [Related]
15. Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial. Gilani F; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH Ann Pharmacother; 2013 Jan; 47(1):43-8. PubMed ID: 23324512 [TBL] [Abstract][Full Text] [Related]
16. Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions. Virani SS Tex Heart Inst J; 2012; 39(2):228-30. PubMed ID: 22740738 [No Abstract] [Full Text] [Related]
17. The MAURO study: baseline characteristics and compliance with guidelines targets. Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C; J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127 [TBL] [Abstract][Full Text] [Related]
18. [Short-term impact of modified blood-lipid reports on physicians' lipid lowering drug prescribing behavior and knowledge improvement on dyslipidemia]. Li JH; Jiang H; Sun XH; Li CC; Ke YN; Yan SK; Wu YF Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):318-22. PubMed ID: 22801311 [TBL] [Abstract][Full Text] [Related]
19. An audit of adherence to heart failure guidelines in an Australian hospital: A pharmacist perspective. Khalil V; Danninger M; Wang W; Khalil H J Eval Clin Pract; 2017 Dec; 23(6):1195-1202. PubMed ID: 28512920 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease]. Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]